News
Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs ...
Hutchmed China reported positive interim results from its phase three ‘SACHI’ trial on Monday, showing that the combination ...
12d
Zacks.com on MSNAstraZeneca Stock Declines 6% in 3 Months: Time to Buy the Dip?AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a ...
An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...
Vodafone Idea, Nykaa, Apollo Hospitals, AstraZeneca Pharma, IndiGo, Adani Energy Solutions, M&M and Puravankara are among the ...
Asad Haider, head of the healthcare business unit within Goldman Sachs Research, now forecasts the market for anti-obesity drugs, particularly those using injectable versions of GLP 1-based drugs, to ...
China has granted some exemptions on US imports from its 125 per cent tariffs and is asking businesses to identify goods that ...
The China-Britain Business Council (CBBC)'s Chair Sir Sherard Cowper-Coles along with a delegation from CBBC’s leadership ...
With the goal to become a top 3 pharma company in China, Novartis has been busy tapping into the expertise of local ...
A recent survey by the China-Australia Chamber of Commerce reveals that Australian businesses are placing great importance on ...
Kicking off this week in Chicago, this year’s American Association for Cancer Research conference will feature presentations ...
Visa, AstraZeneca, Shell, Ocean Power Technologies and Wheeler Real Estate Investment Trust are part of the Zacks top Analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results